Compare Hims and Hers Health Inc (HIMS) vs HP Inc (HPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs HP Inc — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while HP Inc trades at $30.2 (market cap $29.25B). The key difference: HP Inc is far larger — about 4.5× Hims and Hers Health Inc's market cap, and HP Inc pays a 3.7% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and HP Inc for 69 Days on average.
| HIMS | HPQ | |
|---|---|---|
Market Cap | $6.55B | $29.25B |
Volume | 14,842,814 | 10,025,806 |
Sector | Health | Technology |
52-Week High | $62.76 | $35.48 |
52-Week Low | $14.52 | $18.20 |
Typical Hold Time | 21 Days | 69 Days |
Enterprise Value | $7.25B | $35.42B |
Dividend Yield | — | 3.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.
The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.
HPQ trades at $32.44, up 0.62% with a bullish technical signal. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid cash flow generation of $460M in 2025. Valuation appears attractive with P/E of 12.38 and P/S of 0.51, though the company faces headwinds from projected PC market declines in 2027.
HPQ offers value characteristics with reasonable valuation metrics and consistent dividend payments, but faces significant business risks from PC market contraction. Analyst sentiment is mixed with 30.8% buy ratings versus 53.8% holds, reflecting uncertainty about growth prospects amid industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →
